Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01177319 · ClinicalTrials.gov registry record · Phase 2
Glutathione (GSH) In The Treatment of Parkinson's Disease
A Phase 2 study, sponsored by University of South Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT01177319 is a Phase 2 study that has completed, run by University of South Florida. The registered enrollment target is 20 participants.
The verdict
NCT01177319, a Phase 2 study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is an investigator initiated pilot study to examine the effects of GSH in PD. The goal of this study is to acquire some basic data regarding side effects and efficacy of this compound to determine if this is a possible treatment option that could be recommended to interested PD patients.
Interventions
- DRUG Glutathione
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2003-09 |
| Est. Completion | 2007-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01177319
The ClinicalTrials.gov registry entry for NCT01177319 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Glutathione is the first listed.
NCT01177319 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01177319 about?
NCT01177319 is a clinical study titled "Glutathione (GSH) In The Treatment of Parkinson's Disease". This is an investigator initiated pilot study to examine the effects of GSH in PD. The goal of this study is to acquire some basic data regarding side effects and efficacy of this compound to determine if this is a possible treatment option that could be recommended to interested PD patients.
What is the current status of trial NCT01177319?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2003-09. Estimated completion is 2007-03.
What interventions are being tested in trial NCT01177319?
The interventions under investigation include: Glutathione (DRUG).
Who is sponsoring clinical trial NCT01177319?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.